Respiratory & Pulmonary Research
Asthma
Asthma affects millions of children, adolescents, and adults worldwide, causing chronic inflammation and narrowing of the airways. CenExel is committed to advancing innovative asthma treatments through specialized clinical research, helping improve breathing, symptom control, and long-term respiratory health for diverse patient populations.
Advancing Asthma Clinical Research
CenExel delivers high-quality respiratory and pulmonary clinical research services with experienced investigators, advanced diagnostic capabilities, and patient-focused trial management. Our asthma research programs support sponsors from early-stage studies through Phase IV trials with precision and operational excellence.
Improve Respiratory Outcomes
Accelerate Trial Enrollment
Asthma & Respiratory Conditions We Research
Our respiratory research teams support a broad range of asthma and pulmonary-related conditions across pediatric and adult populations.
- Mild Persistent Asthma
- Severe Asthma
- Pediatric Asthma
- Exercise-Induced Asthma
- Allergic Asthma
- Eosinophilic Asthma
- Chronic Cough
- COPD & Asthma Overlap
Why Sponsors Choose CenExel for Asthma Research
Our respiratory research expertise combines scientific precision, advanced pulmonary testing, and strong patient recruitment strategies to support successful asthma clinical trials.
01
Pulmonary Expertise
Our investigators and respiratory specialists bring extensive experience in asthma-focused clinical research.
02
Advanced Diagnostics
We support pulmonary function testing, spirometry, biomarker analysis, and respiratory assessments.
03
Diverse Patient Access
CenExel sites recruit pediatric, adolescent, and adult asthma populations across multiple demographics.
04
Efficient Enrollment
Our nationwide research network helps accelerate enrollment timelines and improve study retention.
Supported Asthma Trial Phases
CenExel supports early and late-phase respiratory clinical research, including inhaled therapies, biologics, and chronic disease management studies.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our respiratory clinical programs include first-in-human studies, dose escalation trials, long-term safety studies, and post-market asthma research initiatives.
Asthma Task Force
CenExel supports a broad range of respiratory and pulmonary clinical research programs focused on innovative asthma therapies, biologics, inhalation treatments, and long-term disease management solutions.






